RecruitingNCT06434337
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
Sponsor
M.D. Anderson Cancer Center
Enrollment
600 participants
Start Date
Jul 23, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
To learn if new HPV tests can provide the same results as standard HPV tests. The findings from this study may aid in the development of new HPV tests that require less equipment and are more accessible.
Eligibility
Sex: FEMALEMin Age: 21 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Novel point-of-care diagnostic test for detecting HPV ("Rice HPV test") for people with human papillomavirus. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 21 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTNovel point-of-care diagnostic test for detecting HPV ("Rice HPV test")
Given by Diagnostic Test
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06434337
Related Trials
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
NCT056729271 location
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
NCT050261381 location
Provider Recommendation and HPV Vaccination
NCT053650481 location
Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology
NCT049013511 location
Pilot study of Anal Neoplasia Treatment in people with HIV Evaluation and monitoring (short title: PANTHER)
ACTRN126240001545051 location